Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-24,618
Closed -$3.15M 100
2016
Q2
$3.15M Buy
24,618
+540
+2% +$71.3K 0.14% 219
2016
Q1
$3.3M Sell
24,078
-31,967
-57% -$4.39M 0.13% 226
2015
Q4
$8.2M Buy
56,045
+640
+1% +$88K 0.25% 141
2015
Q3
$7.48M Sell
55,405
-20,890
-27% -$3.03M 0.34% 106
2015
Q2
$12.4M Sell
76,295
-21,205
-22% -$2.93M 0.24% 138
2015
Q1
$12.6M Buy
+97,500
New +$11.3M 0.23% 92
2014
Q4
Sell
-138,450
Closed -$12.6M 390
2014
Q3
$12.6M Buy
138,450
+6,200
+5% +$579K 0.09% 205
2014
Q2
$12.2M Sell
132,250
-23,233
-15% -$1.99M 0.09% 233
2014
Q1
$13M Buy
155,483
+41,170
+36% +$3.39M 0.1% 187
2013
Q4
$10M Sell
114,313
-8,683
-7% -$710K 0.08% 231
2013
Q3
$9.45M Buy
122,996
+24,416
+25% +$1.91M 0.1% 208
2013
Q2
$7.15M Buy
+98,580
New +$6.64M 0.09% 234

Other funds holding CI

Euclid Advisors's CI Position: Q3 2016 in Review

Euclid Advisors sold out of Cigna (CI) in Q3 2016, closing a stake of 24,618 shares — an estimated $3.15M sold.

Euclid Advisors first reported a position in CI in Q2 2013 and held it in 12 quarters. The position peaked at $13M in Q1 2014. 700 funds tracked by Wall St. Rank hold CI as of Q3 2016.

  • Euclid Advisors reported no remaining Cigna position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 24,618 Cigna shares in Q3 2016, an estimated $3.15M.
  • Euclid Advisors first reported a position in Cigna in Q2 2013 and held it in 12 quarters.
  • Euclid Advisors's Cigna position peaked at $13M in Q1 2014.
  • 700 funds tracked by Wall St. Rank held Cigna as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.